Monash Medical Centre Clayton

Clayton 3168

4 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumor, Bladder Cancer, Breast Cancer, Cervical Cancer, Endometrial Cancer, Esophageal Cancer, Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Cancer, Head and Neck Cancer, Hyperkalemia, Lung Cancer

Studies at this site

• Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age — Recruiting now
• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors — Recruiting now
• Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors — Recruiting now
• The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) — Running, not enrolling
• Avelumab Program Rollover Study — Running, not enrolling
• The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) — Completed
• Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early